Shenghui Qiu

582 total citations
18 papers, 261 citations indexed

About

Shenghui Qiu is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shenghui Qiu has authored 18 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shenghui Qiu's work include Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Shenghui Qiu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (4 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Shenghui Qiu collaborates with scholars based in China and United States. Shenghui Qiu's co-authors include Jinghua Pan, Yun-long Pan, Xiaodong Chu, Yabing Yang, Yiran Zhang, Congcong Chen, Shijin Liu, Yiran Zhang, Zhanzheng Zhao and Hui Ding and has published in prestigious journals such as Free Radical Biology and Medicine, eLife and Cell Death and Disease.

In The Last Decade

Shenghui Qiu

15 papers receiving 259 citations

Peers

Countries citing papers authored by Shenghui Qiu

Since Specialization

Citations

This map shows the geographic impact of Shenghui Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghui Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghui Qiu more than expected).

Fields of papers citing papers by Shenghui Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghui Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghui Qiu. The network helps show where Shenghui Qiu may publish in the future.

Co-authorship network of co-authors of Shenghui Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghui Qiu. A scholar is included among the top collaborators of Shenghui Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghui Qiu. Shenghui Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Paeoniflorin alleviated STZ-induced diabetic retinopathy via regulation of the PDI/ADAM17/MerTK pathway 2025 ·International Immunopharmacology ·(unknown), Hong Guo, Xinyue Xia, Yanmei Liu, Shenghui Qiu, (unknown), Wenqi He, Lai Jin, (unknown), (unknown), Wentao Liu, Haitao Hu	1
2	Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis 2025 ·eLife ·Yiran Zhang, (unknown), Shijin Liu, Haoquan Li, Zhuan Bian, (unknown), Zhanzheng Zhao, Shenghui Qiu, T. Mo, Xiangwei Zhang, (unknown), (unknown), Xiaoxu Zhao, Liang Wang, Yunlong Pan, Jinghua Pan	0
3	Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis 2025 ·Drug Resistance Updates ·(unknown), Yiran Zhang, Simin Luo, Zhan Zhao, T. Mo, (unknown), Haoquan Li, Zhuan Bian, Xiangwei Zhang, Shenghui Qiu, Shijin Liu, Wang Tang, Bo Shi, (unknown), (unknown), (unknown), Jinghua Pan	5
4	Cancer ENO2 Induces Histone Lactylation-Mediated M2 Macrophage Polarization and Facilitates Metastasis of Head and Neck Squamous Cell Carcinoma 2025 ·Engineering ·Chenran Wang, Lin Tan, Maohua Huang, (unknown), (unknown), Lijuan Deng, (unknown), Shenghui Qiu, Xiaoting Chen, Yiming Zhang, (unknown), (unknown), (unknown), Wen‐Cai Ye, Junqiu Zhang, Dongmei Zhang, Xiangning Liu	1
5	Stroke‐Homing Peptide‐DNase1 Alleviates Intestinal Ischemia Reperfusion Injury by Selectively Degrading Neutrophil Extracellular Traps 2025 ·Cell Proliferation ·Tingting Liu, (unknown), Qingshan Xu, (unknown), Shenghui Qiu, (unknown), Na Shen, (unknown), LJ Jin, Tian Tian, Wentao Liu, Lai Jin, Zhongzhi Jia	1
6	The oncogenic role and prognostic value of PXDN in human stomach adenocarcinoma 2024 ·BMC Cancer ·Yuan Tian, Shenghui Qiu, (unknown), (unknown), Hao Hu, Chengcheng Yang, (unknown), Shaomin Chen, (unknown), Hongling Li, (unknown)	0
7	Epidemiology and nomogram for predicting the cancer-specific survival of ovarian granulosa cell tumor: A seer database study 2023 ·Journal of Gynecology Obstetrics and Human Reproduction ·(unknown), Shenghui Qiu, (unknown), (unknown), (unknown), (unknown), Xiangxia Liu, Zi Ye, Jie Cao	0
8	CYP1B1 inhibits ferroptosis and induces anti-PD-1 resistance by degrading ACSL4 in colorectal cancer 2023 ·Cell Death and Disease ·Congcong Chen, Yabing Yang, (unknown), (unknown), (unknown), Shenghui Qiu, Yiran Zhang, (unknown), Jinghua Pan, Yun-long Pan	75
9	Tumor neoantigens: Novel strategies for application of cancer immunotherapy 2023 ·Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ·(unknown), (unknown), Lu Li, (unknown), Shenghui Qiu, (unknown), Xiaodong Chu, (unknown), (unknown), (unknown), Hui Ding, (unknown), Yun-long Pan	20
10	Comparing the diagnostic efficacy of [ ¹⁸ F]FDG PET/CT and [ ¹⁸ F]FDG PET/MRI for detecting bone metastases in breast cancer: a meta-analysis 2023 ·Radiology and Oncology ·(unknown), (unknown), Di Huang, Shenghui Qiu, (unknown), (unknown), Jie Cao	3
11	Epidemiological and survival outcomes of neuroendocrine carcinoma of the breast: a SEER data analysis 2023 ·Translational Cancer Research ·(unknown), (unknown), Xiangxia Liu, (unknown), Shenghui Qiu, (unknown), (unknown), (unknown)	1
12	Targeting FAPα-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis 2023 ·Acta Pharmaceutica Sinica B ·(unknown), Ming Qi, Qi Qi, (unknown), Lijuan Deng, Jinghua Pan, Shenghui Qiu, (unknown), Maohua Huang, Zheng‐Xiang Li, (unknown), Jiapeng Lin, Wen-Yu Lyu, (unknown), (unknown), Xuesong Liu, (unknown), Dongmei Zhang, Wen‐Cai Ye, (unknown)	5
13	Erianin inhibits the growth and metastasis through autophagy-dependent ferroptosis in KRASG13D colorectal cancer 2023 ·Free Radical Biology and Medicine ·(unknown), (unknown), Wen-Yu Lyu, (unknown), (unknown), Ming Qi, Shenghui Qiu, (unknown), Jiapeng Lin, Minfeng Chen, Lijuan Deng	44
14	Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer 2022 ·BMC Cancer ·Xiaodong Chu, (unknown), Ting Huang, Hui Ding, Yiran Zhang, Zhan Zhao, (unknown), Shenghui Qiu, (unknown), Xiaoli Chu, Jinghua Pan, Yunlong Pan	9
15	The Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy 2021 ·Frontiers in Pharmacology ·(unknown), Shijin Liu, Yiran Zhang, Xiaodong Chu, (unknown), Zhanzheng Zhao, Shenghui Qiu, (unknown), Hui Ding, (unknown), Jinghua Pan	59
16	Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors 2021 ·International Journal of Medical Sciences ·Zhan Zhao, Hui Ding, (unknown), Shenghui Qiu, (unknown), (unknown), Xiaodong Chu, (unknown), Jinghua Pan, Yun-long Pan	18
17	A network pharmacology approach for investigating the multi-target mechanisms of Huangqi in the treatment of colorectal cancer 2021 ·Translational Cancer Research ·Xiaodong Chu, Yiran Zhang, (unknown), Zhanzheng Zhao, (unknown), Shenghui Qiu, (unknown), Hui Ding, Ting Huang, Xiaoli Chu, Jinghua Pan, Yun-long Pan	11
18	Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer 2021 ·Disease Markers ·Yabing Yang, Jiaxin Zhou, Shenghui Qiu, (unknown), Jinghua Pan, Yun-long Pan	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact